Since then, I've been trying to look at things from the perspective of the BOD. What motivates them? Why are they dragging their feet on the restatement? Was the notion of an expanded BOD the best they could do to try to apease the stockholders or was it a mandate from the SEC. Perhaps the SEC suggested that as a minimum effort for the BOD to clean up their act.
Again, looking at this situation from the point of view of the BOD; The restatement will be embarrassing, humiliating and most likely incriminating. The Conference call will most likely be embarrassing, humiliating and most likely there will be stockholders calling in with ugly questions. Of course, this will be Shorts problem to deal with all that.
The BOD is procrastinating for what is obviously good reason (from their point of view). However, as usual, they are NOT acting in the best interest of the stockholders. I call on John Shorts to stand up and act like a professional here. This means doing what's best for the company and the stockholders regardless of the "feelings" of the BOD.
I've also been giving some thought to the question of just how long the BOD can hold back on the financial restatement? Surely the SEC has something to say about this?
Any other thoughts here? I have no doubt that once we get past the financial restatements, the stock will take off. So, the BOD is hurting every one of us with their usual antics. So how do we get the BOD to get off their reluctant butts?
Recent RIBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 08:06:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:22:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/20/2023 01:46:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:31:27 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 12/11/2023 10:02:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 10:14:19 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 11/20/2023 01:49:29 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM